Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer, urothelial cancer and genitourinary cancer clinical trials and studies.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Primary care physician use of patient race and polygenic risk scores in medical decision-making
Recurrence Rates for Pediatric Benign Ovarian Neoplasms
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial
Failure of Operative Therapy after Ovarian-Sparing Surgery for Pediatric Benign Ovarian Neoplasms: A Retrospective Review
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Related Stories

What to do if you have a painless lump on the side of your neck

Bike to Beat Cancer is an emotional time for the Schembari family and the rest of Team Bryant

Gastrointestinal (GI) cancers are common and treatable — here’s what you need to know

Transvaginal ultrasound: A tool for early diagnosis of ovarian cancer

Schedule an Appointment